Respiratory Expertise
From Proof of Concept to First Identification of Proof of Efficacy Respiratory clinical research requires a broad range of experience, multidisciplinary support and resources. As an international mid-size CRO, supporting bio/pharma clients in Europe and North America, we provide clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. SGS is recognized as the benchmark R&D partner for quality, reliability, flexibility and customer care. Our comprehensive early and late phase expertise in pulmonary diseases includes asthma, COPD and cystic fibrosis.
Benefits of SGS’s early respiratory drug development expertise: • Defining the best regulatory and scientific approach for compound development • Enrolling patients quickly through our early phase respiratory network
• Testing classic and new pathways, including biologicals and different administration routes • Using non-invasive, invasive and pharmacodynamics challenge methods
Made with FlippingBook Digital Publishing Software